EMA Updates Guidelines on Excipients in Labeling
On October 9, 2017, the European Medicines Agency (EMA) announced that the annex to the guideline on excipients in labeling and packaging of drug products has been updated to include all excipients that must be listed in the labeling and packaging leaflets of drugs and their safety warnings.
The guideline was updated to take into consideration safety concerns not currently addressed in the existing annex, with specific attention to excipients that may affect children or pregnant women. Five new excipients are included, and 10 have been updated with new safety warnings.
Source: EMA
|
|---|
|
Columnists
Webcasts
Outsourcing
Cambrex Development Center in North Carolina Focuses on Continuous Flow
Cambrex will create a new center of excellence for API process development and clinical supply at its High Point, NC facility and expand its API manufacturing facility in Italy.
Lonza Opens Monoplant for Clovis Oncology’s Rubraca
Clovis Oncology and Lonza celebrated the grand opening of a dedicated production train at Lonza’s Visp, Switzerland site for manufacturing Rubraca (rucaparib).
Outsourcing Development: Small-Scale to Commercial
Industry experts discuss the formulation and development issues that should be considered when addressing scale up from small-scale batches to commercial production.
Sponsored Links
